Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-07-14 18:39 | 2020-07-14 | NKTX | Nkarta, Inc. | Flynn James E | 10% owner, Other | Pharmaceutical Preparations | BUY | $18.00 | 1,000,000 | $18,000,000 | 1,209,936 | +476.3% |
| 2020-07-13 23:30 | 2020-07-09 | ALDX | Aldeyra Therapeutics Inc. | PERCEPTIVE ADVISORS LLC | 10% owner | Pharmaceutical Preparations | BUY | $4.25 | 3,200,000 | $13,600,000 | 6,285,458 | +103.7% |
| 2020-07-10 18:06 | 2020-07-08 | LCRDX | Lord Abbett Credit Opportunities Fund | LORD, ABBETT & CO. LLC | Other | Other | BUY | $9.01 | 835,547 | $7,528,278 | 957,448 | +685.4% |
| 2020-07-10 23:17 | 2020-07-08 | RESI | N/A | Deer Park Road Management Company, LP | 10% owner | Other | BUY | $8.40 | 150,000 | $1,260,000 | 7,408,569 | +2.1% |
| 2020-07-10 23:32 | 2020-07-08 | ETNB | N/A | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | Other | BUY | $27.50 | 275,000 | $7,562,500 | 3,436,214 | +8.7% |
| 2020-07-10 21:22 | 2020-07-09 | CFOO | China Foods Holdings Ltd. | Kong Xiao Jun | Director, Officer, 10% owner - CEO and CFO | Medicinal Chemicals & Botanical Products | BUY | $0.32 | 13,950,000 | $4,464,000 | 18,951,000 | +278.9% |
| 2020-07-10 23:18 | 2020-07-10 | VCNX | VACCINEX, INC. | FRIEDBERG ALBERT | Director, 10% owner | Pharmaceutical Preparations | BUY | $3.55 | 1,126,760 | $3,999,998 | 1,710,093 | +193.2% |
| 2020-07-10 02:59 | 2020-07-08 | CMCT | Creative Media & Community Trust Corp | RESSLER RICHARD S | Director, 10% owner | Real Estate Investment Trusts | BUY | $25.00 | 106,518 | $2,662,950 | 106,518 | +100.0% |
| 2020-07-10 02:58 | 2020-07-08 | CMCT | Creative Media & Community Trust Corp | CIM Capital, LLC | Other | Real Estate Investment Trusts | BUY | $25.00 | 95,245 | $2,381,125 | 95,245 | +100.0% |
| 2020-07-10 02:57 | 2020-07-08 | CMCT | Creative Media & Community Trust Corp | Kuba Shaul | Director, 10% owner | Real Estate Investment Trusts | BUY | $25.00 | 106,518 | $2,662,950 | 106,518 | +100.0% |
| 2020-07-10 02:59 | 2020-07-08 | CMCT | Creative Media & Community Trust Corp | Shemesh Avraham | Director, 10% owner | Real Estate Investment Trusts | BUY | $25.00 | 106,518 | $2,662,950 | 106,518 | +100.0% |
| 2020-07-09 22:06 | 2019-07-02 | BOB | N/A | DONNELLEY FINANCIAL SOLUTIONS 06/FA | Director | Other | BUY | $1,000.00 | 20,000 | $20,000,000 | 20,000 | +100.0% |
| 2020-07-07 23:06 | 2020-07-02 | DNB | N/A | Daffron Stephen C. | Officer - President | Other | BUY | $22.00 | 100,000 | $2,200,000 | 100,000 | +100.0% |
| 2020-07-08 00:21 | 2020-06-18 | AAACX | N/A | Bosch Anthony R. | Director, Officer, 10% owner - President & Secretary | Other | BUY | $10.39 | 105,875 | $1,099,851 | 292,705 | +56.7% |
| 2020-07-07 23:07 | 2020-07-02 | DNB | N/A | Jabbour Anthony M | Director, Officer - Chief Executive Officer | Other | BUY | $22.00 | 200,000 | $4,400,000 | 200,000 | +100.0% |
| 2020-07-07 23:07 | 2020-07-02 | DNB | N/A | Massey Richard N | Director | Other | BUY | $22.00 | 100,000 | $2,200,000 | 100,000 | +100.0% |
| 2020-07-08 03:58 | 2020-07-02 | CLR | N/A | Hamm Harold | Director, Officer, 10% owner - Executive Chairman | Other | BUY | $17.77 | 2,679,849 | $47,625,740 | 12,293,669 | +27.9% |
| 2020-07-07 23:12 | 2020-06-22 | PSTI | Pluri Inc. | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $8.04 | 199,686 | $1,604,856 | 3,411,446 | +6.2% |
| 2020-07-07 20:15 | 2020-07-02 | CRGS | N/A | GOLISANO B THOMAS | 10% owner | Other | BUY | $125,000.00 | 37,500 | $4,687,500,000 | 37,500 | +100.0% |
| 2020-07-07 23:18 | 2020-06-29 | SRT | N/A | CSP Management Ltd | Director, 10% owner | Other | BUY | $4.87 | 1,540,041 | $7,500,000 | 1,540,041 | +100.0% |
| 2020-07-06 23:03 | 2020-06-26 | SLNO | SOLENO THERAPEUTICS INC | Sinclair Andrew | Director | Pharmaceutical Preparations | BUY | $1.65 | 3,333,330 | $5,499,995 | 10,302,602 | +47.8% |
| 2020-07-07 00:06 | 2020-07-06 | PANA | Nuvation Bio Inc. | EcoR1 Panacea Holdings, LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 390,000 | $3,900,000 | 390,000 | +100.0% |
| 2020-07-06 23:02 | 2020-06-26 | SLNO | SOLENO THERAPEUTICS INC | Abingworth LLP | 10% owner | Pharmaceutical Preparations | BUY | $1.65 | 3,333,330 | $5,499,995 | 10,302,602 | +47.8% |
| 2020-07-07 00:24 | 2020-07-01 | XLRN | N/A | CELGENE CORP /DE/ | 10% owner | Other | BUY | $92.50 | 108,108 | $9,999,990 | 6,971,772 | +1.6% |
| 2020-07-07 00:25 | 2020-07-01 | AWH | Aspira Women's Health Inc. | SCHULER JACK W | 10% owner | In Vitro & In Vivo Diagnostic Substances | BUY | $3.50 | 2,285,715 | $8,000,003 | 25,394,517 | +9.9% |
| 2020-07-02 23:58 | 2020-06-30 | FUSN | N/A | JOHNSON & JOHNSON | 10% owner | Other | BUY | $17.00 | 725,000 | $12,325,000 | 3,670,516 | +24.6% |
| 2020-07-02 23:17 | 2020-06-30 | AKUS | N/A | PARMAR KUSH | Director, 10% owner | Other | BUY | $17.00 | 294,117 | $4,999,989 | 1,094,101 | +36.8% |
| 2020-07-02 14:00 | 2020-07-01 | N/A | Blackstone Real Estate Income Trust, Inc. | Agarwal A.J. | Director, Officer - President | Real Estate Investment Trusts | BUY | $10.55 | 189,638 | $2,000,000 | 189,638 | +100.0% |
| 2020-07-02 23:02 | 2020-06-30 | FUSN | N/A | HealthCap VII, L.P. | 10% owner | Other | BUY | $17.00 | 240,000 | $4,080,000 | 3,807,247 | +6.7% |
| 2020-07-02 23:03 | 2020-06-30 | FUSN | N/A | Khuong Chau Quang | Director | Other | BUY | $17.00 | 898,000 | $15,266,000 | 192,100 | +100.0% |
| 2020-07-02 23:16 | 2020-06-30 | AKUS | N/A | Preston Heather | Director | Other | BUY | $17.00 | 299,999 | $5,099,983 | 5,882 | +100.0% |
| 2020-07-03 00:20 | 2020-06-30 | AKUS | N/A | EcoR1 Capital, LLC | 10% owner | Other | BUY | $17.00 | 1,176,000 | $19,992,000 | 1,975,984 | +147.0% |
| 2020-07-02 23:00 | 2020-06-30 | AKUS | N/A | Cormorant Asset Management, LP | Other | Other | BUY | $17.00 | 290,000 | $4,930,000 | 789,989 | +58.0% |
| 2020-07-02 23:48 | 2020-07-01 | BLFS | BIOLIFE SOLUTIONS INC | Casdin Partners Master Fund, L.P. | 10% owner | Electromedical & Electrotherapeutic Apparatus | BUY | $14.50 | 990,583 | $14,363,454 | 5,840,107 | +20.4% |
| 2020-07-02 23:02 | 2020-06-30 | FUSN | N/A | Christenson Johan | Director | Other | BUY | $17.00 | 240,000 | $4,080,000 | 3,807,247 | +6.7% |
| 2020-07-02 23:31 | 2020-06-30 | AKUS | N/A | RA CAPITAL MANAGEMENT, L.P. | 10% owner | Other | BUY | $17.00 | 825,000 | $14,025,000 | 2,281,249 | +56.7% |
| 2020-07-03 03:50 | 2020-06-30 | AKUS | N/A | 5AM Ventures V, L.P. | 10% owner | Other | BUY | $17.00 | 294,117 | $4,999,989 | 1,094,101 | +36.8% |
| 2020-07-02 23:16 | 2020-06-30 | AKUS | N/A | Novartis Bioventures Ltd | Other | Other | BUY | $17.00 | 125,000 | $2,125,000 | 1,181,258 | +11.8% |
| 2020-07-02 23:34 | 2020-06-30 | FUSN | N/A | TPG Group Holdings (SBS) Advisors, Inc. | Other | Other | BUY | $17.00 | 250,000 | $4,250,000 | 2,551,794 | +10.9% |
| 2020-07-02 23:02 | 2020-06-30 | FUSN | N/A | ORBIMED ADVISORS LLC | Director | Other | BUY | $17.00 | 898,000 | $15,266,000 | 192,100 | +100.0% |
| 2020-07-03 02:31 | 2020-07-02 | LQDA | N/A | Eshelman Ventures, LLC | 10% owner | Other | BUY | $8.00 | 1,875,000 | $15,000,000 | 7,034,744 | +36.3% |
| 2020-07-02 00:30 | 2020-06-30 | AKUS | N/A | Chang Carmen | 10% owner | Other | BUY | $17.00 | 588,235 | $9,999,995 | 4,294,207 | +15.9% |
| 2020-07-01 23:14 | 2020-06-30 | AKUS | N/A | Pivotal bioVenture Partners Fund I, L.P. | 10% owner | Other | BUY | $17.00 | 294,117 | $4,999,989 | 1,794,088 | +19.6% |
| 2020-07-02 00:45 | 2020-06-30 | AKUS | N/A | New Enterprise Associates 16, L.P. | 10% owner | Other | BUY | $17.00 | 588,235 | $9,999,995 | 4,294,207 | +15.9% |
| 2020-07-02 00:34 | 2020-06-30 | AKUS | N/A | Makhzoumi Mohamad | 10% owner | Other | BUY | $17.00 | 588,235 | $9,999,995 | 4,294,207 | +15.9% |
| 2020-07-02 00:49 | 2020-06-30 | AKUS | N/A | Behbahani Ali | 10% owner | Other | BUY | $17.00 | 588,235 | $9,999,995 | 4,294,207 | +15.9% |
| 2020-07-02 00:32 | 2020-06-30 | AKUS | N/A | Florence Anthony A. Jr. | 10% owner | Other | BUY | $17.00 | 588,235 | $9,999,995 | 4,294,207 | +15.9% |
| 2020-07-02 00:57 | 2020-06-30 | AKUS | N/A | Sonsini Peter W. | 10% owner | Other | BUY | $17.00 | 588,235 | $9,999,995 | 4,294,207 | +15.9% |
| 2020-07-02 00:42 | 2020-06-30 | AKUS | N/A | Walker Paul Edward | 10% owner | Other | BUY | $17.00 | 588,235 | $9,999,995 | 4,294,207 | +15.9% |
| 2020-07-01 23:48 | 2020-06-29 | MGTA | Dianthus Therapeutics, Inc. /DE/ | Booth Bruce | Director | Pharmaceutical Preparations | BUY | $8.00 | 1,250,000 | $10,000,000 | 1,250,000 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.